Good news!
Of course, for leftist journalists with Trump Derangement Syndrome it was compulsory to mention that South Africa will not receive this vaccine immediately while President Trump is in office. Even though for this article it was kind of irrelevant to mention it.
"The breakthrough HIV prevention shot lenacapavir has arrived in Eswatini [formerly Swaziland] and Zambia just months after U.S. approval, marking what advocates call an unusually fast global deployment of a game-changing drug to LMICs that need it most ...
A small, but significant start: Each country received 500 doses of the twice-yearly injection, which provides near-complete protection against HIV.
The deliveries mark the first step toward providing ~2 million doses by 2028 through the Global Fund, the U.S. State Department, and Gilead Sciences, which developed the vaccine. ..."
Figure 1 Chemical structure, mechanism of action, and advantages of lenacapavir (Source)
No comments:
Post a Comment